Compounds > eosine yellowish-(ys)
Page last updated: 2024-08-21

eosine yellowish-(ys) and Diabetic Nephropathies

eosine yellowish-(ys) has been researched along with Diabetic Nephropathies in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's4 (100.00)2.80

Authors

AuthorsStudies
Chen, B; Chen, J; Chen, S; Chen, ZQ; Gu, XL; Han, YL; Hu, J; Liang, FX; Luo, ZH; Wang, KX; Wu, S; Zhang, YL; Zhou, T1
Li, C; Ma, L; Shao, D; Xu, A; Yu, J; Zhai, B1
Huang, X; Kong, J; Li, X; Wang, X; Wu, H; Xu, F; Yang, X; Yu, P; Zhang, L; Zhen, C1
Birnbaum, Y; Chen, H; Nylander, S; Tran, D; Ye, Y1

Other Studies

4 other study(ies) available for eosine yellowish-(ys) and Diabetic Nephropathies

ArticleYear
[Protective effect and mechanism of electroacupuncture of "Biao-Ben" acupoints combination for mitochondrial dysfunction in diabetic nephropathy rats].
    Zhen ci yan jiu = Acupuncture research, 2022, Sep-25, Volume: 47, Issue:9

    Topics: Actins; Acupuncture Points; Animals; Blood Glucose; Body Weight; Catalase; Cholesterol, HDL; Cholesterol, LDL; Collagen; Creatinine; Diabetic Nephropathies; Electroacupuncture; Eosine Yellowish-(YS); Fibronectins; Glutathione; Glycated Hemoglobin; Hematoxylin; Male; Malondialdehyde; Mitochondria; Nitrogen; Obesity; Rats; Rats, Wistar; Sirtuin 1; Streptozocin; Superoxide Dismutase; Triglycerides; Urease; Xanthine Oxidase

2022
Transient receptor potential canonical 6 knockdown ameliorated diabetic kidney disease by inhibiting nuclear factor of activated T cells 2 expression in glomerular mesangial cells.
    Renal failure, 2022, Volume: 44, Issue:1

    Topics: Animals; Cells, Cultured; Collagen; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Eosine Yellowish-(YS); Fibronectins; Glucose; Hematoxylin; Mesangial Cells; Rats; RNA, Messenger; RNA, Small Interfering; Streptozocin; T-Lymphocytes; TRPC6 Cation Channel

2022
Lupenone improves type 2 diabetic nephropathy by regulating NF-κB pathway-mediated inflammation and TGF-β1/Smad/CTGF-associated fibrosis.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2023, Volume: 118

    Topics: Animals; Anti-Inflammatory Agents; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Eosine Yellowish-(YS); Fibrosis; Hematoxylin; Inflammation; Kidney; Mice; NF-kappa B; Proteinuria; Rats; Transforming Growth Factor beta1

2023
Ticagrelor and Dapagliflozin Have Additive Effects in Ameliorating Diabetic Nephropathy in Mice with Type-2 Diabetes Mellitus.
    Cardiovascular drugs and therapy, 2022, Volume: 36, Issue:5

    Topics: Albumins; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Benzhydryl Compounds; Creatinine; Cystatin C; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Eosine Yellowish-(YS); Glucose; Glucosides; Hematoxylin; Inflammasomes; Insulins; Kidney; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Periodic Acid; Proto-Oncogene Proteins c-akt; Ticagrelor

2022